Pediatric bone density and fracture

Current Osteoporosis Reports

Volumn 5, Issue 3, 2007, Pages 128-134

  Von Scheven, Emily ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; VITAMIN D;

BONE DENSITOMETRY; BONE DENSITY; BONE MASS; CHILDHOOD; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; OSTEOPENIA; OSTEOPOROSIS; PEDIATRICS; PHYSICAL ACTIVITY; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW;

EID: 35348847981     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-007-0028-7     Document Type: Review

References (50)

1. Cassidy JT, Langman CB, Allen SH, Hillman LS: Bone mineral metabolism in children with juvenile rheumatoid arthritis. Pediatr Clin North Am 1995, 42:1017-1033.
2. Teegarden D, Proulx WR, Martin BR, et al.: Peak bone mass in young women. J Bone Miner Res 1995, 10:711-715.
3. Recker RR, Davies KM, Hinders SM, et al.: Bone gain in young adult women. JAMA 1992, 268:2403-2408.
4. Bailey DA, Faulkner RA, McKay HA: Growth, physical activity, and bone mineral acquisition. Exerc Sport Sci Rev 1996, 24:233-266.
5. Wren TA, Kim PS, Janicka A, et al.: Timing of peak bone mass: discrepancies between CT and DXA. J Clin Endocrinol Metab 2007, 92:938-941.
6. Kalkwarf HJ, Zemel BS, Gilsanz V, et al.: The Bone Mineral Density in Childhood Study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007, 92:2087-2099. This is the first large, multiethnic, prospective report of normal BMD in children.
7. Carter DR, Bouxsein ML, Marcus R: New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992, 7:137-145.
8. Fewtrell MS; British Paediatric & Adolescent Bone Group: Bone densitometry in children assessed by dual x-ray absorptiometry: uses and pitfalls. Arch Dis Child 2003, 88:795-798.
9. Kalender WA: Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography. Osteoporos Int 1992, 2:82-87.
10. Lewis MK, Blake GM, Fogelman I: Patient dose in dual x-ray absorptiometry. Osteoporos Int 1994, 4:11-15.
11. Sawyer A, Bachrach LK, Fung EB: Bone Densitometry in Growing Patients: Guidelines for Clinical Practice. Totowa, NJ: Humana Press, 2006. Useful guidelines for establishing standardized procedures for performing densitometry assessments in children.
12. Simpson DE, Dontu VS, Stephens SE, et al.: Large variations occur in bone density measurements of children when using different software. Nucl Med Commun 2005, 26:483-487.
13. Gilsanz V, Boechat MI, Roe TF, et al.: Gender differences in vertebral body sizes in children and adolescents. Radiology 1994, 190:673-677.
14. Kovanlikaya A, Loro ML, Hangartner TN, et al.: Osteopenia in children: CT assessment. Radiology 1996, 198:781-784.
15. Bell NH, Shary J, Stevens J, et al.: Demonstration that bone mass is greater in black than in white children. J Bone Miner Res 1991, 6:719-723.
16. McCormick DP, Ponder SW, Fawcett HD, Palmer JL: Spinal bone mineral density in 335 normal and obese children and adolescents: evidence for ethnic and sex differences. J Bone Miner Res 1991, 6:507-513.
17. Wuster C, Albanese C, De Aloysio D, et al.: Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res 2000, 15:1603-1614.
18. Baroncelli GI, Federico G, Bertelloni S, et al.: Bone quality assessment by quantitative ultrasound of proximal phalanxes of the hand in healthy subjects aged 3-21 years. Pediatr Res 2001, 49:713-718.
19. Zadik Z, Price D, Diamond G: Pediatric reference curves for multi-site quantitative ultrasound and its modulators. Osteoporos Int 2003, 14:857-862.
20. Gafni RI, Baron J: Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr 2004, 144:253-257. This report highlights common mistakes in the interpretation of DXA results in children.
21. Lewiecki EM, Watts NB, McClung MR, et al.: Official positions of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 2004, 89:3651-3655.
22. Molgaard C, Thomsen BL, Prentice A, et al.: Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997, 76:9-15.
23. Chan GM, Hess M, Hollis J, Book LS: Bone mineral status in childhood accidental fractures. Am J Dis Child 1984, 138:569-570.
24. Jones G, Ma D, Cameron F: Bone density interpretation and relevance in Caucasian children aged 9-17 years of age: insights from a population-based fracture study. J Clin Densitom 2006, 9:202-209.
25. Clark EM, Ness AR, Bishop NJ, Tobias JH: Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006, 21:1489-1495.
26. von Scheven E, Gordon CM, Wypij D, et al.: Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study. J Pediatr Endocrinol Metab 2006, 19:821-830.
27. Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology 2001, 142:5050-5055.
28. Theoleyre S, Wittrant Y, Tat SK, et al.: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004, 15:457-475.
29. Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332:305-311.
30. Bianchi ML: How to manage osteoporosis in children. Best Pract Res Clin Rheumatol 2005, 19:991-1005.
31. NIH Consensus Conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994, 272:1942-1948.
32. Goulding A, Rockell JE, Black RE, et al.: Children who avoid drinking cow's milk are at increased risk for prepubertal bone fractures. J Am Diet Assoc 2004, 104:250-253.
33. Winzenberg T, Shaw K, Fryer J, Jones G: Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials [review]. BMJ 2006, 333:775.
34. Bassett CA, Donath A, Macagno F, et al.: Diphosphonates in the treatment of myositis ossificans. Lancet 1969, 2(7625):845.
35. Glorieux FH, Bishop NJ, Plotkin H, et al.: Cyclic administration of Pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998, 339:947-952.
36. Grissom LE, Harcke HT: Radiographic features of bisphosphonate therapy in pediatric patients. Pediatr Radiol 2003, 33:226-229.
37. Park EA: The imprinting of nutritional disturbances on the growing bone. Pediatrics 1964, 33(suppl):815-862.
38. Rauch F, Travers R, Plotkin H, Glorieux FH: The effects of intravenous Pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 2002, 110:1293-1299.
39. Weber M, Roschger P, Fratzl-Zelman N, et al.: Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta. Bone 2006, 39:616-622.
40. Brumsen C, Hamdy NA, Papapoulos SE: Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis [review]. Medicine (Baltimore) 1997, 76:266-283.
41. Whyte MP, Wenkert D, Clements KL, et al.: Bisphosphonate-induced osteopetrosis. N Engl J Med 2003, 349:457-463.
42. Graepel P, Bentley P, Fritz H, et al.: Reproduction toxicity studies with Pamidronate. Arzneimittelforschung 1992, 42:654-667.
43. Patlas N, Golomb G, Yaffe P, et al.: Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999, 60:68-73.
44. Minsker DH, Manson JM, Peter CP: Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 1993, 121:217-223.
45. Munns CF, Rauch F, Ward L, Glorieux FH: Maternal and fetal outcome after long-term Pamidronate treatment before conception: a report of two cases. J Bone Miner Res 2004, 19:1742-1745.
46. Hamann KL, Lane NE: Parathyroid hormone update. Rheum Dis Clin North Am 2006, 32:703-719.
47. Hodsman AB, Bauer DC, Dempster DW, et al.: Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005, 26:688-703.
48. Hind K, Burrows M: Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials. Bone 2007, 40:14-27.
49. Gilsanz V, Wren TA, Sanchez M, et al.: Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res 2006, 21:1464-1474.
50. Schumacher HR: Primer on the Rheumatic Diseases, edn 10. Atlanta, GA: Arthritis Foundation; 1993.